Cannabinoids and Terpenes As Chemotaxonomic Markers in Cannabis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Toxicity and Neurotoxic Effects of Monoterpenoids: in Insects and Earthworms Joel R
Entomology Publications Entomology 1-9-1991 Toxicity and Neurotoxic Effects of Monoterpenoids: In Insects and Earthworms Joel R. Coats Iowa State University, [email protected] Laura L. Karr Iowa State University Charles D. Drewes Iowa State University Follow this and additional works at: http://lib.dr.iastate.edu/ent_pubs Part of the Entomology Commons, Environmental Health Commons, Other Animal Sciences Commons, and the Plant Biology Commons The ompc lete bibliographic information for this item can be found at http://lib.dr.iastate.edu/ ent_pubs/377. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Book Chapter is brought to you for free and open access by the Entomology at Iowa State University Digital Repository. It has been accepted for inclusion in Entomology Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Toxicity and Neurotoxic Effects of Monoterpenoids: In Insects and Earthworms Abstract The insecticidal activity of several monoterpenoids from essential oils was evaluated against insect pests. Toxicity tests illustrated the bioactivity of d-limonene, α-terpineol, β-myrcene, linalool, and pulegone against insects, including the house fly, the German cockroach, the rice weevil, and the western corn rootworm. Bioassays were conducted to assess their toxicity via topical application, fumigation, ingestion, and ovicidal exposures. Growth, reproduction and repellency were also evaluated in the German cockroach. Non-invasive electrophysiological recordings were used with an earthworm to investigate neurotoxic effects of the monoterpenoids. Relevant monoterpenoid bioassay results in the literature are also discussed. Disciplines Entomology | Environmental Health | Other Animal Sciences | Plant Biology | Plant Sciences Comments Reprinted (adapted) with permission from Naturally Occurring Pest Bioregulators, 449(20); 305-316. -
Retention Indices for Frequently Reported Compounds of Plant Essential Oils
Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5. -
Medical Cannabis Q&A
Medical Cannabis Q&A 1. What is medical cannabis? The term “medical cannabis” is used to describe products derived from the whole cannabis plant or its extracts containing a variety of active cannabinoids and terpenes, which patients take for medical reasons, after interacting with and obtaining authorization from their health care practitioner. 2. What are the main active ingredients? The chemical ingredients of cannabis are called cannabinoids. The two main therapeutic ones are: THC:CBD a. Tetrahydrocannabinol (THC) is a partial agonist of CB1 and CB2 receptors. It is psychoactive and produces the euphoric effect. Each cannabis product will contain THC and CBD, however b. Cannabidiol (CBD) has a weak affinity for CB1 and CB2 receptors and appears the THC: CBD ratio will differ to exert its activity by enhancing the positive effects of the body’s endogenous depending on the product. cannabinoids. 3. Why do patients take it? Medical cannabis may be used to alleviate symptoms for a variety of conditions. It has most commonly been used in neuropathic pain and other chronic pain conditions. There is limited, but developing clinical evidence surrounding its safety and efficacy, and it does not currently have an approved Health Canada indication. 4. How do patients take it? Cannabis can be smoked, vaporized, taken orally, sublingually, topically or rectally. Different routes of administration will result in different pharmacokinetic and pharmacodynamic properties of the drug. 5. Is it possible to develop dependence on medical cannabis? Yes, abrupt discontinuation after long-term use may result in withdrawal symptoms. Additionally, chronic use may result in psychological dependence. -
In This Issue
Issue n° 2 MAY 2019 In this issue----- ABACUS project in brief… - ABACUS project in brief The 3-year ABACUS project aims to provide a range of new molecules - Focus on WP1 & WP2 synthetized from microalgae and therefore to bring competitive innovative ingredients based on terpenes for fragrances markets and - Events of interest carotenoids for cosmetics and nutraceutics markets. The concept of ABACUS project associates several interdisciplinary approaches in order to support a high- value product market development stemming from: - Selection and biological engineering of microalgal strains and oriented photosynthesis of terpenoids; - Technological development of algae biomass production systems to optimize cultivation and photosynthesis of terpenoids; - Technological development of the downstream processing steps to reduce time and costs, and to optimize environmental acceptability; - Market development based on new algae-derived ingredients and structuration of new bio-based value chains. To reach its targets, ABACUS takes benefits from a wide range of expertise by gathering 2 large industrial partners (Proteus and Sensient Cosmetics Technologies), 3 algae SMEs (Algafuel, Microphyt and Subitec) and 4 RTOs (CEA, SAMS, CSIC and KIT). Since May 2017, a cooperative work has unfolded between all consortium members whose work is distributed in 10 defined work packages, altogether tailored to reach the objectives by the end of the project. With this second issue of our project’s newsletter, we are pleased to introduce WP1 & WP2 achievements to date. Product and market Market survey acceptances & roadmap Applicability Algae selection Fractionation Process design Up scaling Communication Management Ethics requirements WP1: Solidification of market opportunities and products specifications Two market studies for terpenoid and carotenoid molecules were performed during the first three months of the project. -
Terpenoids Commonly Found in Cannabis Sativa Do Not Modulate the Actions of Phytocannabinoids Or Endocannabinoids on TRPA1 and TRPV1 Channels
Cannabis and Cannabinoid Research Volume 5, Number 4, 2020 Mary Ann Liebert, Inc. DOI: 10.1089/can.2019.0099 Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels Marika Heblinski,1,2 Marina Santiago,3 Charlotte Fletcher,1,4 Jordyn Stuart,1,3,4 Mark Connor,3 Iain S. McGregor,1,4 and Jonathon C. Arnold1,2,* Abstract Introduction: Cannabis sativa produces hundreds of bioactive compounds, including cannabinoids and terpe- noids. It has been proposed that cannabinoids act in synergy with terpenoids to produce the entourage effect, a concept used to explain the therapeutic benefits of medicinal cannabis. One molecular explanation for the en- tourage effect is that the terpenoids augment the actions of cannabinoids at their molecular drug targets in cells. We recently reported that terpenoids commonly found in cannabis do not influence the functional effects of D9-tetrahydrocannabinol (D9-THC) on cannabinoid 1 and cannabinoid 2 receptors. The present study aimed to extend on this research by examining whether terpenoids influence the effects of phytocannabinoids and endo- cannabinoids on human transient receptor potential ankyrin 1 (hTRPA1) and human transient receptor potential vanilloid 1 (hTRPV1) channels heterologously expressed in mammalian cells. Materials and Methods: The activity of terpenoids, phytocannabinoids, and endocannabinoids was assessed in inducible HEK Flp-In T-Rex cells transfected with hTRPA1 and hTRPV1 channels, respectively. Real-time changes in intracellular calcium ([Ca]i) were measured using the Calcium 5 dye and a FlexStation 3 plate reader. Results: a-pinene, b-pinene, b-caryophyllene, linalool, limonene, b-myrcene or a-humulene did not affect [Ca]i in hTRPA1 and hTRPV1 overexpressing cells. -
Dispensary Selection Information
______________________________________________________________________________________ State of Vermont Department of Public Safety Marijuana Registry [phone] 802-241-5115 45 State Drive [fax] 802-241-5230 Waterbury, Vermont 05671-1300 [email] [email protected] www.medicalmarijuana.vermont.gov Dispensary Selection Information IMPORTANT INFORMATION CONTAINED BELOW WHEN COMPLETING THE FORMS TO REGISTER AS A PATIENT WITH THE VERMONT MARIJUANA REGISTRY (VMR). Materials provided by each dispensary are attached to assist patient applicants designating a dispensary. Registered patients may purchase marijuana, marijuana infused products, seeds, and clones from a registered dispensary. Registered patients who designate a dispensary may purchase marijuana products and cultivate marijuana in a single secure indoor facility. Registered patients who elect to cultivate marijuana in a single secure indoor facility must provide the address and location to the VMR on his or her application. Any updates to the address and/or location of the single secure indoor facility must be submitted in writing via email or mail to the contact information below. Registered patients may only purchase marijuana, marijuana infused products, seeds, and clones from one dispensary and must designate the dispensary of his or her choice on their application. Registered patients may only change dispensaries every 30 days. After 30 days, a registered patient may change his or her designated dispensary by submitting a completed Cardholder Information Notification form and a $25 processing fee. The VMR will issue the registered patient a new registry identification card with a new registry identification number. ALL registered patients and caregivers MUST schedule appointments prior to going to their designated dispensary to obtain marijuana, this includes seed and clones. -
Big-Catalogue-English-2020.Pdf
PAS CH SIO UT N D ® CATALOGUE English SEED COMPANY Feminized, autoflower and regular cannabis seeds AMSTERDAM, ESTABLISHED 1987 for recreational and medical use. Amsterdam - Maastricht YOUR PASSION OUR PASSION DUTCH PASSION 02 Contents Welcome to Dutch Passion Welcome to Dutch Passion 02 Dutch Passion was the second Cannabis Seed Company in the world, established in Amsterdam in 1987. It is our mission to supply Bestsellers 2019 02 the recreational and medical home grower with the highest quality cannabis products available in all countries where this is legally Regular, Feminized and Autoflower 03 allowed. Cannabinoids 03 Medical use of cannabis 03 After many years of dedication Dutch Passion remains a leading supplier of the world’s best cannabis genetics. Our experienced Super Sativa Seed Club 04 team do their utmost to maintain the quality of our existing varieties and constantly search for new ones from an extensive network Special Cannabinoids / THC-Victory 05 of worldwide sources. We supply thousands of retailers and seed distributors around the world. Dutch Outdoor 06 High Altitude 09 CBD Rich 10 Dutch Passion have never been afraid to upset conventional thinking; we invented feminized seeds in the 1990’s and more recently Latin America 13 have pioneered the introduction of 10-week Autoflower seeds which have helped make life even easier for the self-sufficient Classics 14 cannabis grower. CBD-rich medical cannabis genetics is a new area that we are proud to be leading. Skunk Family 19 Orange Family 21 The foundation of our success is the genetic control we have over our strains and the constant influx of new genetics that we obtain Blue Family 24 worldwide. -
(12) Patent Application Publication (10) Pub. No.: US 2016/0279073 A1 Donsky Et Al
US 20160279073A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0279073 A1 Donsky et al. (43) Pub. Date: Sep. 29, 2016 (54) TERPENE AND CANNABINOID Publication Classification FORMULATIONS (51) Int. Cl. A63L/01 (2006.01) (71) Applicant: FULL SPECTRUM A63L/05 (2006.01) LABORATORIES, LTD., Dublin 2 A636/85 (2006.01) (IE) A63L/352 (2006.01) A63L/05 (2006.01) (72) Inventors: Marc Donsky, Denver, CO (US); A6II 47/36 (2006.01) Robert Winnicki, Denver, CO (US) A 6LX 9/27 (2006.01) A63L/045 (2006.01) (21) Appl. No.: 15/033,023 (52) U.S. Cl. CPC ............... A6 IK3I/01 (2013.01); A61K 9/127 (22) PCT Fed: Oct. 31, 2014 (2013.01); A61 K3I/015 (2013.01); A61 K 31/045 (2013.01); A61K 31/352 (2013.01); (86) PCT No.: PCT/B2O14/OO3156 A61 K3I/05 (2013.01); A61K 47/36 (2013.01); A61K 36/185 (2013.01) S 371 (c)(1), (2) Date: Apr. 28, 2016 (57) ABSTRACT The present invention provides stable, fast-acting liposome and micelle formulations of terpenes, hemp oil, cannabi Related U.S. Application Data noids, or mixtures of a cannabinoid and terpenes or hemp oil and cannabinoids that are Suitable for pharmaceutical and (60) Provisional application No. 61/898,024, filed on Oct. nutraceutical applications. Also provided are methods for 31, 2013. the manufacture of micelle and liposomal formulations. US 2016/0279.073 A1 Sep. 29, 2016 TERPENE AND CANNABINOID medical conditions, including glaucoma, AIDS wasting, FORMULATIONS neuropathic pain, treatment of spasticity associated with multiple Sclerosis, fibromyalgia and chemotherapy-induced PRIORAPPLICATION INFORMATION nausea. -
Personal Use Cannabis Rules Special Adopted New Rules: N.J.A.C
NEW JERSEY CANNABIS REGULATORY COMMISSION Personal Use Cannabis Rules Special Adopted New Rules: N.J.A.C. 17:30 Adopted: August 19, 2021 by New Jersey Cannabis Regulatory Commission, Dianna Houenou, Chair. Filed: August 19, 2021 Authority: N.J.S.A. 24:6I-31 et seq. Effective Date: August 19, 2021 Expiration Date: August 19, 2022 This rule may be viewed or downloaded from the Commission’s website at nj.gov/cannabis. These rules are adopted pursuant to N.J.S.A. 24:6I-34(d)1a of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act, N.J.S.A. 24:6I- 31 et seq., and became effective upon acceptance for filing by the Office of Administrative Law. The specially adopted new rules shall be effective for a period not to exceed one year from the date of filing of the new rules, that is, until August 19, 2022. The Commission has provided this special adoption to the Attorney General, State Treasurer, Commissioner of Health, and Commissioner of Banking and Insurance for a consultation period, after which the Commission anticipates filing a proposal to readopt these rules with amendments reflecting the results of that consultation. In accordance with N.J.S.A. 24:6I-34(d)1b the rules, as readopted, will become effective upon acceptance for filing by the Office of Administrative Law if filed on or before the expiration date of the rules published herein. The adopted amendments will be effective upon publication in the New Jersey Register. Federal Standards Analysis The Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act obliges the Cannabis Regulatory Commission to promulgate rules necessary or proper to enable it to carry out the Commission’s duties, functions, and powers with respect to overseeing the development, regulation, and enforcement of activities associated with the personal use of cannabis pursuant to P.L.2021, c.16. -
A10 Anabolic Steroids Hardcore Info
CONTENTS GENERAL INFORMATION 3 Anabolic steroids – What are they? 4 How do they Work? – Aromatisation 5 More molecules – More problems 6 The side effects of anabolic steroids 7 Women and anabolic steroids 8 Injecting steroids 9 Abscesses – Needle Exchanges 10 Intramuscular injection 11 Injection sites 12 Oral steroids – Cycles – Stacking 13 Diet 14 Where do steroids come from? Spotting a counterfeit 15 Drug Information – Drug dosage STEROIDS 16 Anadrol – Andriol 17 Anavar – Deca-Durabolin 18 Dynabolon – Durabolin – Dianabol 19 Esiclene – Equipoise 20 Primobolan Depot – Proviron – Primobolan orals – Pronobol 21 Sustanon – Stromba, Strombaject – Testosterone Cypionate Testosterone Enanthate 22 Testosterone Propionate – Testosterone Suspension 23 Trenbolone Acetate – Winstrol OTHER DRUGS 24 Aldactone – Arimidex 25 Clenbuterol – Cytomel 26 Ephedrine Hydrochloride – GHB 27 Growth Hormone 28 Insulin 30 Insulin-Like Growth Factor-1 – Human Chorionic Gonadotrophin 31 Tamoxifen – Nubain – Recreational Drugs 32 Steroids and the Law 34 Glossary ANABOLIC STEROIDS People use anabolic steroids for various reasons, some use them to build muscle for their job, others just want to look good and some use them to help them in sport or body building. Whatever the reason, care needs to be taken so that as little harm is done to the body as possible because despite having muscle building effects they also have serious side effects especially when used incorrectly. WHAT ARE THEY? Anabolic steroids are man made versions of the hormone testosterone. Testosterone is the chemical in men responsible for facial hair, deepening of the voice and sex organ development, basically the masculine things Steroids are in a man. used in medicine to treat anaemia, muscle weakness after These masculine effects surgery etc, vascular are called the androgenic disorders and effects of testosterone. -
Seed Catalogue 2016
SEED CATALOGUE 2016 BREEDER OF CHAMPIONS Since 1986 CBD Critical Cure 4 CBD Blue Shark 4 Pineapple Express Auto 5 Cookies Kush Blue Mammoth Auto 5 Sweet Tooth Auto 6 Malana Bomb Auto 6 Triple Cheese Sin Tra Bajo Auto 7 Critical Kush Auto 7 Blue Cheese Auto 8 NYC Diesel Auto 8 Critical Kush Cookies Kush 9 Triple Cheese 9 Critical Kush 10 Pineapple Chunk 10 Liberty Haze Ayahuasca Purple 11 Bad Azz Kush 11 Tangerine Dream 12 Ayahuasca Liberty Haze 12 Purple Blue Cheese 13 LSD 13 G13 Haze 14 Bad Azz Kush Peppermint Kush 14 Vanilla Kush 15 Sweet Tooth 15 Laughing Buddha 16 G-13 Haze Utopia Haze 16 Amnesia Lemon 17 Dr. Grinspoon 17 Vanilla Kush Morning Glory 18 Chronic Thunder 18 Acapulco Gold 19 Red Diesel 19 Dr. Grinspoon Red Cherry Berry 20 Phatt Fruity 20 Red Dragon 21 8 Ball Kush 21 Morning Glory Violator Kush 22 Top Dawg 22 Honey B 23 www.barneysfarm.com Amnesia Lemon Crimea Blue 23 Pineapple CBD Critical Cure (Medical feminized) Express Auto 20% Sativa. 80% Indica 30% Sativa. 70% Indica 600 gr/m² 600 gr/m² 90/100 cm 100/110 cm 55/60 days 60/65 days End September from Germination 5.5% 8.0% 14% 1.2 - 1.4% € 28 € 22 € 42 € 32 € 76 € 58 Barneys Farm / CBD Crew – Critical Cure. Pineapple Chunk X Super Auto. The legendary Indica dominant Critical Kush crossed with Shanti Baba’s CBD Pineapple Express Auto is the autoflowering version of the original Pineapple Enhanced strain. The fast flowering CBD Critical Cure plant produces huge, Chunk. -
15/Gram - $50/3.5 Grams Select Flower - $13/Gram** STRAIN DESCRIPTIONS
30 Mozzone Boulevard, Taunton, MA 02780 http://commonwealthaltcare.org/ (508) 738-6380 Flower Menu - $15/gram - $50/3.5 Grams Select Flower - $13/gram** STRAIN DESCRIPTIONS Strain Lineage Type Available In TAC Effects and Aroma Mendo Purps x Sativa 1.0 G THCA 13.1 Hashy with savory undertones. Great body high, very happy and Triangle Kush #4 x Hybrid CBGA .4 Item 9** Stardawg Haze comforting Hybrid 1.0 G THCA 10.5 A hybrid strain, perfect for pain, relaxation, inflammation, and stress CBC .6 Echo** relief Gorilla Glue #4 x Sativa 1.0 G THCA 20.8 A sweet mandarin orange aroma with woody undertones. Great for Tangie Hybrid CBGA .8 Citrus Sap mood elevation, stress, inflammation, and pain relief Blue Dream x Hybrid 1.0 G THCA 21.4 Blueberry aroma with spice and sweet herbal notes. Effects are Snow Lotus CBGA .3 uplifting and promote relaxation and focus. Great for stress, pain, Dream Lotus inflammation, and spasticity White Widow x Hybrid 1.0 G THCA 17.2 A nutty, coffee aroma with earthy undertones. Heavily relaxing Skywalker CBGA .6 effects, boosting both mood and appetite. Great for stress relief and White Walker Kush treating anorexia and cachexia Moonshine Haze x Hybrid 1.0 G THCA 21.5 Spicy, sweet, and fruit aromas. A balanced hybrid that’s both Double Purple CBGA 1.1 Moonrise Doja energetic and relaxing Afghani x Thai x Indica 1.0 G THCA 23.2 Strong indica strain that emanates sweet blueberry aromas. Heavy Purple Thai CBGA .5 3.5 G relaxation effects, paired with a euphoric sensation.